# Lupin Limited – FDA Inspection, Oct 18, 2018

Source: https://www.keypedia.com/records/fda_inspections/lupin-limited/19307e9d-44c9-4acd-9d20-d09b96f0a73c
Source feed: FDA_Inspections

> FDA inspection 1069052 of Lupin Limited, October 18, 2018. Classification: Official Action Indicated (OAI). 5 citations under 21 CFR parts 211 and 820. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1069052
- Company Name: Lupin Limited
- Inspection Date: 2018-10-18
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Generic Drug Evaluation
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 5

## Related Documents

- [FDA Inspection 1275680 - 2025-07-17](https://www.keypedia.com/records/fda_inspections/lupin-limited/3eb0abd3-7b93-490d-8975-7c91722b0398)
- [FDA Inspection 1014374 - 2017-06-16](https://www.keypedia.com/records/fda_inspections/lupin-limited/01c316a2-7af0-49ff-8e17-c771a1cd03fb)
- FDA Inspection 1020760 - 2017-06-08
- FDA Inspection 924395 - 2015-03-27

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/yasamin-ameri/73021772-c960-4c65-aa30-cb490866ee58)

Company: https://www.keypedia.com/companies/lupin-limited/d2616722-956d-4898-88a7-c22b7bd321a2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c